Lary Walker

Last updated
Lary Craswell Walker
Born
Columbus, Ohio, United States
NationalityAmerican
Alma mater Louisiana State University (BS)
Tulane University (MS, PhD)
Known forPrion-like mechanisms in neurodegenerative diseases
Neuropathology of Alzheimer's disease
Proteopathy
Awards Metlife Foundation Award for Medical Research in Alzheimer's Disease (2014) [1] [2]
Alexander von Humboldt Research Award (2016) [3]
Peter Bassoe Lectureship of the American Neuropsychiatric Association (2017) [4]
Scientific career
Fields
Institutions Tulane University
Emory University
Johns Hopkins University
University of Greifswald
Parke-Davis/Warner-Lambert
University of Tübingen

Lary Walker is an American neuroscientist and researcher at Emory University in Atlanta, Georgia. He is Associate Director of the Goizueta Alzheimer's Disease Research Center at Emory, [5] and he is known for his research on the role of abnormal proteins in the causation of Alzheimer's disease. [1] [6]

Contents

Education and career

Walker received his Bachelor of Science degree from Louisiana State University, and his Master of Science and PhD degrees from Tulane University. Following a German Academic Exchange (DAAD) Fellowship at the University of Kassel and a National Institutes of Health (NIH) postdoctoral fellowship at Emory University, he moved to the Neuropathology Laboratory of Donald L. Price at Johns Hopkins University, where he began work on the biological basis of Alzheimer's disease. [7] [8] In 1995 he became head of the Alzheimer's disease drug discovery program at Parke-Davis/Warner-Lambert in Ann Arbor, Michigan. In 2003 he returned to Emory University, where he is the Marie and E.R. Snelling Professor of Neurology. [9] [10]

Research

Biology of Aβ (senile) plaques

Walker's early research established that a variety of neurons are involved in the formation of Aβ plaques, one of the pathological hallmarks of Alzheimer's disease. [11] [12] [13] With Dale Schenk at Athena Neurosciences (later part of Élan Pharmaceuticals), he discovered that antibodies to the protein can enter the brain from the cerebrospinal fluid and selectively bind to Aβ plaques and cerebral Aβ-amyloid angiopathy (CAA). [14] [15] Based on his work with animal models of Alzheimer's disease, Walker has proposed that humans are uniquely vulnerable to Alzheimer's disease. [16] [17] [18]

Prion-like properties of disease-causing proteins

Since the late 1990s, Walker's research has been directed toward the mechanisms that drive the misfolding and aggregation of the Aβ protein in the living brain. In collaboration with Mathias Jucker at the University of Tübingen, he discovered that the accumulation of Aβ can be initiated in transgenic mouse models by a prion-like mechanism in which 'seeds' of abnormal Aβ precipitate the formation of plaques and CAA. [19] [20] [6] In 2000, Walker and Harry LeVine introduced the term 'proteopathy' (also known as 'proteinopathy') to describe diseases characterized by the misfolding and aggregation of proteins. [21] This terminology has been applied to a number of neurodegenerative disorders and amyloidoses, including tauopathies such as Pick's disease, synucleinopathies such as Parkinson's disease and Lewy Body Dementia, systemic amyloidoses, and others. [22] [23] [24]

Awards

Walker received the Metlife Foundation Award for Medical Research in Alzheimer's Disease in 2014, [1] the Alexander von Humboldt Research Award in 2016, [3] and the Peter Bassoe Lectureship of the American Neuropsychiatric Association in 2017. [4]

Bibliography

Selected reviews

Selected research reports

Complete list of published work

Selected book chapters

References

  1. 1 2 3 "MetLife Foundation Awards for Medical Research in Alzheimer's Disease" (PDF). Archived from the original (PDF) on 13 October 2018.
  2. "2014 MetLife Foundation Awards". YouTube . 30 May 2014.
  3. 1 2 "Alexander von Humboldt Foundation".
  4. 1 2 "American Neuropsychiatric Association Annual Meeting 2017".
  5. "Emory Goizueta ADRC Faculty and Staff".
  6. 1 2 Miller, Greg (2009). "Could they all be prion diseases?" . Science. 326 (5958): 1337–1339. Bibcode:2009Sci...326.1337M. doi:10.1126/science.326.5958.1337. PMID   19965731.
  7. "ORCID iD Lary Walker".
  8. Price, DL; Kitt, CA; Struble, RG; Whitehouse, PJ; Cork, LC; Walker, LC (1985). "Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia". Annals of the New York Academy of Sciences. 457 (1): 35–51. Bibcode:1985NYASA.457...35P. doi:10.1111/j.1749-6632.1985.tb20798.x. PMID   2869729. S2CID   26512854.
  9. "Emory Neurology Faculty".
  10. "Emory Medicine Dean's Letter September 2016".
  11. Walker, LC; Kitt, CA; Cork, LC; Struble, RG; Dellovade, TL; Price, DL (1988). "Multiple transmitter systems contribute neurites to individual senile plaques". Journal of Neuropathology and Experimental Neurology. 47 (2): 138–144. doi:10.1097/00005072-198803000-00006. PMC   11223644 . PMID   2828554. S2CID   25208183.
  12. Patrella, C; Grazia Di Certo, M; Barbato, C; Gabanella, F; Ralli, M; Greco, A; Possenti, R; Severini, C (2019). "Neuropeptides in Alzheimer's Disease: An Update". Current Alzheimer Research. 16 (6): 544–558. doi:10.2174/1567205016666190503152555. PMID   31456515. S2CID   201656098.
  13. Hof, Patrick R. (1997). "Morphology and Neurochemical Characteristics of the Vulnerable Neurons in Brain Aging and Alzheimer's Disease". European Neurology. 37 (2): 71–81. doi:10.1159/000117414. ISSN   1750-1326. PMID   9058061.
  14. Walker, LC; Price, DL; Voytko, ML; Schenk, DB (1994). "Labeling of cerebral amyloid in vivo with a monoclonal antibody". Journal of Neuropathology and Experimental Neurology. 53 (4): 377–383. doi:10.1097/00005072-199407000-00009. PMC   9887729 . PMID   8021711. S2CID   22652110.
  15. Masters, CL; Cappai, R; Barnham, KJ; Villemagne, VL (2006). "Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics". Journal of Neurochemistry. 97 (6): 1700–1725. doi: 10.1111/j.1471-4159.2006.03989.x . PMID   16805778. S2CID   38283117.
  16. Walker, LC; Jucker, M (2017). "The exceptional vulnerability of humans to Alzheimer's disease". Trends in Molecular Medicine. 23 (6): 534–545. doi:10.1016/j.molmed.2017.04.001. PMC   5521004 . PMID   28483344.
  17. Haque, RU; Levey, AI (2019). "Alzheimer's Disease: A Clinical Perspective and Future Nonhuman Primate Research Opportunities". Proceedings of the National Academy of Sciences USA. 116 (52): 26224–26229. Bibcode:2019PNAS..11626224H. doi: 10.1073/pnas.1912954116 . PMC   6936673 . PMID   31871211.
  18. "Is Alzheimer's Disease a Uniquely Human Disorder?".
  19. Jucker, M; Walker, LC (2013). "Self-propagation of pathogenic protein aggregates in neurodegenerative diseases". Nature. 501 (7465): 45–51. Bibcode:2013Natur.501...45J. doi:10.1038/nature12481. PMC   3963807 . PMID   24005412.
  20. Knowles, TP; Vendruscolo, M; Dobson, CM (2014). "The amyloid state and its association with protein misfolding diseases". Nature Reviews Molecular Cell Biology. 15 (6): 384–396. doi:10.1038/nrm3810. PMID   24854788. S2CID   46357173.
  21. Walker, LC; LeVine, H (2000). "The cerebral proteopathies". Neurobiology of Aging. 21 (4): 559–561. doi:10.1016/s0197-4580(00)00160-3. PMID   10924770. S2CID   54314137.
  22. Chen-Plotkin, Alice S.; Lee, Virginia M.-Y.; Trojanowski, John Q. (2010). "TAR DNA-binding protein 43 in neurodegenerative disease". Nature Reviews Neurology. 6 (4): 211–220. doi:10.1038/nrneurol.2010.18. ISSN   1759-4758. PMC   2892118 . PMID   20234357.
  23. Holmes, BB; Furman, JL; Mahan, TE; Yamasaki, TR; Mirgaha, H; Eades, WC; Belaygorod, L; Cairns, NJ; Holtzman, DM; Diamond, MI (2014). "Proteopathic tau seeding predicts tauopathy in vivo". Proceedings of the National Academy of Sciences USA. 111 (41): E4376-85. Bibcode:2014PNAS..111E4376H. doi: 10.1073/pnas.1411649111 . PMC   4205609 . PMID   25261551.
  24. Metrick, MA; do Carmo Ferreira, N; Saijo, E; Hughson, AG; Kraus, A; Orrú, C; Miller, MW; Zanusso, G; Ghetti, B; Vendruscolo, M; Caughey, B (2019). "Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons". Proceedings of the National Academy of Sciences USA. 116 (46): 23029–23039. Bibcode:2019PNAS..11623029M. doi: 10.1073/pnas.1909322116 . PMC   6859373 . PMID   31641070.